These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 31123156

  • 1. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA, Øllgaard JC, Tofte N, Tarnow L, Wang Z, Ahluwalia TS, Jorsal A, Theilade S, Parving HH, Hansen TW, Hazen SL, Pedersen O, Rossing P.
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [Abstract] [Full Text] [Related]

  • 2. Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S, Rasmussen DGK, Hansen TW, Tofte N, Winther SA, Holm Nielsen S, Theilade S, Karsdal MA, Genovese F, Rossing P.
    Diabetes Care; 2019 Sep; 42(9):1760-1768. PubMed ID: 31262950
    [Abstract] [Full Text] [Related]

  • 3. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
    Gencer B, Li XS, Gurmu Y, Bonaca MP, Morrow DA, Cohen M, Bhatt DL, Steg PG, Storey RF, Johanson P, Wang Z, Hazen SL, Sabatine MS.
    J Am Heart Assoc; 2020 May 18; 9(10):e015331. PubMed ID: 32366163
    [Abstract] [Full Text] [Related]

  • 4. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H, Gutiérrez OM, Shlipak MG, Katz R, Ix JH, Sarnak MJ, Cushman M, Rhee EP, Kimmel PL, Vasan RS, Schrauben SJ, Feldman HI, Seegmiller JC, Brunengraber H, Hostetter TH, Schelling JR, CKD Biomarkers Consortium.
    Am J Kidney Dis; 2022 Oct 18; 80(4):502-512.e1. PubMed ID: 35351578
    [Abstract] [Full Text] [Related]

  • 5. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS, Wu PH, Hung WW, Lin MY, Zhen YY, Hung WC, Chang JM, Tsai JR, Chiu YW, Hwang SJ, Tsai YC.
    J Clin Endocrinol Metab; 2024 Jul 12; 109(8):2097-2105. PubMed ID: 38267025
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Sotoodehnia N, Budoff M, DiDonato JA, McKnight B, Tang WHW, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D.
    J Am Heart Assoc; 2021 Sep 07; 10(17):e020646. PubMed ID: 34398665
    [Abstract] [Full Text] [Related]

  • 7. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W, Huang A, Zhu H, Liu X, Huang X, Huang Y, Cai X, Lu J, Huang Y.
    Med J Aust; 2020 Oct 07; 213(8):374-379. PubMed ID: 32959366
    [Abstract] [Full Text] [Related]

  • 8. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
    Winther SA, Øllgaard JC, Hansen TW, von Scholten BJ, Reinhard H, Ahluwalia TS, Wang Z, Gæde P, Parving HH, Hazen S, Pedersen O, Rossing P.
    PLoS One; 2021 Oct 07; 16(3):e0244402. PubMed ID: 33657115
    [Abstract] [Full Text] [Related]

  • 9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P.
    Kidney Int; 2017 Nov 07; 92(5):1242-1248. PubMed ID: 28712855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A, Iwamoto T, Tsutsumi Y, Nakashima A, Yamamoto I, Yokoyama K, Yokoo T, Urashima M.
    Clin Exp Nephrol; 2016 Oct 07; 20(5):731-739. PubMed ID: 26676906
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
    Mohammedi K, Potier L, Belhatem N, Matallah N, Hadjadj S, Roussel R, Marre M, Velho G.
    Cardiovasc Diabetol; 2016 Jan 07; 15():5. PubMed ID: 26743116
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M, Nickler M, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Nutrition; 2018 Jan 07; 45():135-141.e1. PubMed ID: 28870405
    [Abstract] [Full Text] [Related]

  • 17. Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with ESKD Receiving Maintenance Hemodialysis.
    Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD.
    Clin J Am Soc Nephrol; 2019 Feb 07; 14(2):261-267. PubMed ID: 30665924
    [Abstract] [Full Text] [Related]

  • 18. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.
    Diabetes Care; 2019 Jun 07; 42(6):1112-1119. PubMed ID: 30885954
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM, Allenspach M, Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A.
    Atherosclerosis; 2015 Dec 07; 243(2):638-44. PubMed ID: 26554714
    [Abstract] [Full Text] [Related]

  • 20. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC, Croyal M, Ene L, Aguesse A, Billon-Crossouard S, Krempf M, Lemoine S, Guebre-Egziabher F, Juillard L, Soulage CO.
    Toxins (Basel); 2019 Nov 01; 11(11):. PubMed ID: 31683880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.